2024-12-01 2025-11-30 false No description of principal activity Acting Office - Tax and Accounts 1.0 15297090 bus:FullAccounts 2024-12-01 2025-11-30 15297090 bus:Micro-entities 2024-12-01 2025-11-30 15297090 bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 15297090 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 15297090 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 15297090 2024-12-01 2025-11-30 15297090 2025-11-30 15297090 bus:RegisteredOffice 2024-12-01 2025-11-30 15297090 core:WithinOneYear 2025-11-30 15297090 core:AfterOneYear 2025-11-30 15297090 2023-11-20 15297090 bus:Director1 2024-12-01 2025-11-30 15297090 bus:Director1 2025-11-30 15297090 bus:Director1 2023-11-20 2024-11-30 15297090 bus:CompanySecretary1 2024-12-01 2025-11-30 15297090 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 15297090 2023-11-20 2024-11-30 15297090 2024-11-30 15297090 core:WithinOneYear 2024-11-30 15297090 core:AfterOneYear 2024-11-30 15297090 bus:EntityAccountantsOrAuditors 2023-11-20 2024-11-30 15297090 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 15297090 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 15297090 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 15297090 core:Non-currentFinancialInstruments 2025-11-30 15297090 core:Non-currentFinancialInstruments 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15297090
England and Wales

 

 

 

HYDRAGENX LTD


Unaudited Financial Statements
 


Period of accounts

Start date : 01 December 2024

End date : 30 November 2025
 
 
 
£
2025
£
   
£
2024
£
Current assets 6,319  5 
Creditors: amount falling due within one year (6,314)
Net current assets/(liabilities) 5  5 
Total assets less current liabilities 5  5 
Net assets/(liabilities) 5  5 
 
Capital and reserves 5  5 
 



Notes to the Accounts
Statutory Information
Hydragenx Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 15297090, registration address 167-169 Great Portland Street, London, W1W 5PF, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2024: 0).

Director's Responsibilities:
  1. For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
Mohamed Ali Saad Huss Mohamed
Director

Date approved: 28 August 2026
1